We’re taking a closer look at new research highlighting the risks of tick-borne diseases. A study by Quest Diagnostics, published in JAMA Network Open, found that nearly one in three patients with antibodies for Lyme disease also had antibodies for at least one other tick-borne pathogen. Joining us to break down the findings and explain what they mean for diagnosis and treatment is Dr. Emily Schindler, Medical Director of Infectious Disease and Immunology at Quest Diagnostics.